A/H5N1 Prepandemic Influenza Vaccine (Whole Virion, Vero Cell-Derived, Inactivated) [Vepacel®]

ISSN： 0012-6667

Source： Drugs, Vol.72, Iss.11, 2012-07, pp. : 1543-1557

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted; Prepandrix™): a guide to its use as an active immunization against influenza A subtype H5N1 virus

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 25, Iss. 3, 2009-03 ,pp. : 5-9

Adis International

Access to resources Recommend Favorite

Adjuvant boosts H5N1 influenza vaccine immunogenicity

Inpharma, Vol. 1, Iss. 1602, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Physicochemical and Immunological Characterization of N,N,N-Trimethyl Chitosan-Coated Whole Inactivated Influenza Virus Vaccine for Intranasal Administration

By Hagenaars Niels Mastrobattista Enrico Verheul Rolf Mooren Imke Glansbeek Harrie Heldens Jacco Bosch Han Jiskoot Wim

Pharmaceutical Research, Vol. 26, Iss. 6, 2009-06 ,pp. : 1353-1364

Springer Publishing Company

Access to resources Recommend Favorite

Oseltamivir in Seasonal, Avian H5N1 and Pandemic 2009 A/H1N1 Influenza: Pharmacokinetic and Pharmacodynamic Characteristics

By Widmer Nicolas

Clinical Pharmacokinetics, Vol. 49, Iss. 11, 2010-11 ,pp. : 741-765

Adis International

Access to resources Recommend Favorite

HAd-H5HA vaccine protects against H5N1 influenza in mice

Inpharma, Vol. 1, Iss. 1524, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite